Apatinib Mesylate trials for Breast cancer

All Apatinib Mesylate trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Apatinib Mesylate for Breast cancer

• Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC
  NCT05192798 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
  NCT05019690 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
  NCT06255392 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

How many trials study Apatinib Mesylate for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.